Effect of drug-eluting metal stents in benign esophageal stricture: An in vivo animal study

Endoscopy

Volumn 41, Issue 5, 2009, Pages 449-456

  Jeon, S R ^a   Eun, S H ^a   Shim, C S ^a   Ryu, C B ^a   Kim, J O ^a   Cho, J Y ^a   Lee, J S ^a   Lee, M S ^a   Jin, S Y ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOY; ANTINEOPLASTIC AGENT; NITINOL; PACLITAXEL;

ANIMAL; ARTICLE; CELL DIVISION; DISEASE MODEL; DOG; DRUG EFFECT; DRUG ELUTING STENT; EPITHELIUM; EQUIPMENT DESIGN; ESOPHAGOSCOPY; ESOPHAGUS; ESOPHAGUS STENOSIS; FOCAL ADHESION; GRANULATION TISSUE; MUCOSA; PATHOLOGY;

ALLOYS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIVISION; DISEASE MODELS, ANIMAL; DOGS; DRUG-ELUTING STENTS; EPITHELIUM; EQUIPMENT DESIGN; ESOPHAGEAL STENOSIS; ESOPHAGOSCOPY; ESOPHAGUS; FOCAL ADHESIONS; GRANULATION TISSUE; MUCOUS MEMBRANE; PACLITAXEL;

EID: 67849122684     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0029-1214607     Document Type: Article

References (34)

1. Shah JN. Benign refractory esophageal strictures: widening the endoscopist's role. Gastrointest Endosc 2006; 63: 164-167 (Pubitemid 41827803)
2. Lew RJ, Kochman ML. A review of endoscopic methods of esophageal dilation. J Clin Gastroenterol 2002; 35: 117-126 (Pubitemid 34815848)
3. Said A, Brust DJ, Gaumnitz EA et al. Predictors of early recurrence of benign esophageal strictures. Am J Gastroenterol 2003; 98: 1252-1256 (Pubitemid 36741518)
4. Song HY, Park SI, Do YS et al. Expandable metallic stent placement in patients with benign esophageal strictures: results of long-term follow- up. Radiology 1997; 203: 131-136
5. Fiorini A, Fleischer D, Valero J et al. Self-expandable metal coil stents in the treatment of benign esophageal strictures refractory to conventional therapy: a case series. Gastrointest Endosc 2000; 52: 259-262 (Pubitemid 30650269)
6. Evrard S, Le Moine O, Lazaraki G et al. Self-expanding plastic stents for benign esophageal lesions. Gastrointest Endosc 2004; 60: 894-900 (Pubitemid 39655462)
7. Repici A, Conio M, De Angelis C et al. Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures. Gastrointest Endosc 2004; 60: 513-519 (Pubitemid 39311531)
8. Fry SW, Fleischer DE. Management of a refractory benign esophageal stricture with a new biodegradable stent. Gastrointest Endosc 1997; 45: 179-182 (Pubitemid 27085926)
9. Tanaka T, Takahashi M, Nitta N et al. Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial. Digestion 2006; 74: 199-205 (Pubitemid 46622790)
10. Jung IS. Development of newly designed fully covered self-expandible metal stent for the treatment of refractory benign esophageal stricture and evaluation of its tissue response in dogs [dissertation]. Asan: Soon Chun Hyang University, 2007
11. Lee DH. Drug-eluting stent in gastrointestinal disease. Korean J Gastroenterol 2007; 49: 294-299
12. Lee DK, Kim HS, Kim KS et al. The effect on porcine bile duct of ametallic stent covered with a paclitaxel-incorporated membrane. Gastrointest Endosc 2005; 61: 296-301 (Pubitemid 40261091)
13. Baron TH, Burqart LJ, Pochron NL. An internally covered (lined) self-expanding metal esophageal stent: tissue response in a porcine model. Gastrointest Endosc 2006; 65: 263-267 (Pubitemid 44062507)
14. Little AG, Naunbeim KS, Ferguson MK et al. Surgical management of esophageal strictures. Ann Thorac Surg 1988; 45: 144-147 (Pubitemid 18056441)
15. Yim HB, Jacobson BC, Saltzman JR et al. Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction. Gastrointest Endosc 2001; 53: 329-332 (Pubitemid 32207318)
16. Domschke W, Foerster EC, Matek Wet al. Self-expanding mesh stent for esophageal cancer stenosis. Endoscopy 1990; 22: 134-136 (Pubitemid 20199833)
17. Kozarek RA, Ball TJ, Patterson DJ. Metallic self-expanding stent application in the upper gastrointestinal tract: caveats and concerns. Gastrointest Endosc 1992; 38: 1-6
18. Maetani I, Ogawa S, Hoshi H et al. Self-expanding metal stents for palliative treatment of malignant biliary and duodenal stenoses. Endoscopy 1994; 26: 701-704 (Pubitemid 24361215)
19. Feretis C, Benakis P, Dimopoulos C et al. Palliation of malignant gastric outlet obstruction with self-expanding metal stents. Endoscopy 1996; 28: 225-228 (Pubitemid 26136918)
20. Pinto IT. Malignant gastric and duodenal stenosis: palliation by peroral implantation of a self-expanding metallic stent. Cardiovasc Intervent Radiol 1997; 20: 431-434 (Pubitemid 27512033)
21. Venu RP, Pastika BJ, Kini M et al. Self-expandable metal stents for malignant gastric outlet obstruction: a modified technique. Endoscopy 1998; 30: 553-558 (Pubitemid 28409974)
22. Yates 3rd MR, Morgan DE, Baron TH. Palliation of malignant gastric and small intestinal strictures with self-expandable metal stents. Endoscopy 1998; 30: 266-272 (Pubitemid 28223112)
23. Soetikno RM, Lichtenstein DR, Vandervoort J et al. Palliation of malignant gastric outlet obstruction using an endoscopically placed Wallstent. Gastrointest Endosc 1998; 47: 267-270 (Pubitemid 28155350)
24. Seo YS, Park JJ, Kim BG et al. Segmental amputation of esophagus with bronchial-wall rupture during removal of a stent for benign esophageal stricture. Gastrointest Endosc 2006; 64: 141-143 (Pubitemid 43927749)
25. Nam DS, Lee WK. Development of polymer coating method for stable stent coating using chemical bond between metal surface and polymer. J Kor Pharm Sci 2007; 37: 7-14
26. Lee KB, Chun HJ, Kim YB et al. Mechanical characterization of self-expandable esophageal metal stents. Korean J Gastrointest Endosc 2001; 23: 61-68
27. Parness J, Horwitz SB. Taxol binds to polymerized tubulin in vitro. J Cell Biol 1981; 91: 479-487 (Pubitemid 12215635)
28. Roussel E, Belanger MM, Couet J. G2/M blockade by paclitaxel induces caveolin-1 expression in A549 lung cancer cells: caveolin-1 as amarker of cytotoxicity. Anticancer Drugs 2004; 15: 961-967 (Pubitemid 39557483)
29. Torres K, Horwitz SB. Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 1998; 58: 3620-3626 (Pubitemid 28376560)
30. Fan W. Possible mechanism of paclitaxel-induced apoptosis. Biochem Pharmacol 1999; 57: 1215-1221
31. Kalinowski M, Alfke H, Kleb B et al. Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction: possible topical application in malignant bile duct obstructions. Invest Radiol 2002; 37: 399-404 (Pubitemid 34680202)
32. Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engl J Med 1995; 332: 1004-1014
33. Dhanikula AB, Panchagnula R. Localized paclitaxel delivery. Int J Pharm 1999; 183: 85-100 (Pubitemid 29257954)
34. Mani G, Feldman MD, Patel D et al. Coronary stents: a materials perspective. Biomaterials 2007; 28: 1689-1710 (Pubitemid 46080469)